Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Genomic dynamics of species and mobile genetic elements in a prolonged blaIMP-4-associated carbapenemase outbreak in an Australian hospital.

Kizny Gordon A, Phan HTT, Lipworth SI, Cheong E, Gottlieb T, George S, Peto TEA, Mathers AJ, Walker AS, Crook DW, Stoesser N.

J Antimicrob Chemother. 2020 Apr 1;75(4):873-882. doi: 10.1093/jac/dkz526.

2.

A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections.

Sigfrid L, Perfect C, Rojek A, Longuere KS, Lipworth S, Harriss E, Lee J, Salam A, Carson G, Goossens H, Horby P.

BMC Med. 2019 Sep 6;17(1):170. doi: 10.1186/s12916-019-1387-5.

3.

Improved Performance Predicting Clarithromycin Resistance in Mycobacterium abscessus on an Independent Data Set.

Lipworth S, Hough N, Buchanan R, Smith EG, Robinson E, Alexander E, Peto T, Crook D, Walker T.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00400-19. doi: 10.1128/AAC.00400-19. Print 2019 Aug. No abstract available.

4.

Academic medicine: the continuing challenges.

Mashar M, Kilgour J, Nanapragasam H, Lipworth S.

Clin Teach. 2020 Feb;17(1):81-85. doi: 10.1111/tct.13023. Epub 2019 Apr 26.

PMID:
31025798
5.

SNP-IT Tool for Identifying Subspecies and Associated Lineages of Mycobacterium tuberculosis Complex.

Lipworth S, Jajou R, de Neeling A, Bradley P, van der Hoek W, Maphalala G, Bonnet M, Sanchez-Padilla E, Diel R, Niemann S, Iqbal Z, Smith G, Peto T, Crook D, Walker T, van Soolingen D.

Emerg Infect Dis. 2019 Mar;25(3):482-488. doi: 10.3201/eid2503.180894.

6.

Whole-Genome Sequencing for Predicting Clarithromycin Resistance in Mycobacterium abscessus.

Lipworth S, Hough N, Leach L, Morgan M, Jeffery K, Andersson M, Robinson E, Smith EG, Crook D, Peto T, Walker T.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01204-18. doi: 10.1128/AAC.01204-18. Print 2019 Jan.

7.

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, Bi L, Beckert P, Bonnet M, Bradley P, Cabibbe AM, Cancino-Muñoz I, Caulfield MJ, Chaiprasert A, Cirillo DM, Clifton DA, Comas I, Crook DW, De Filippo MR, de Neeling H, Diel R, Drobniewski FA, Faksri K, Farhat MR, Fleming J, Fowler P, Fowler TA, Gao Q, Gardy J, Gascoyne-Binzi D, Gibertoni-Cruz AL, Gil-Brusola A, Golubchik T, Gonzalo X, Grandjean L, He G, Guthrie JL, Hoosdally S, Hunt M, Iqbal Z, Ismail N, Johnston J, Khanzada FM, Khor CC, Kohl TA, Kong C, Lipworth S, Liu Q, Maphalala G, Martinez E, Mathys V, Merker M, Miotto P, Mistry N, Moore DAJ, Murray M, Niemann S, Omar SV, Ong RT, Peto TEA, Posey JE, Prammananan T, Pym A, Rodrigues C, Rodrigues M, Rodwell T, Rossolini GM, Sánchez Padilla E, Schito M, Shen X, Shendure J, Sintchenko V, Sloutsky A, Smith EG, Snyder M, Soetaert K, Starks AM, Supply P, Suriyapol P, Tahseen S, Tang P, Teo YY, Thuong TNT, Thwaites G, Tortoli E, van Soolingen D, Walker AS, Walker TM, Wilcox M, Wilson DJ, Wyllie D, Yang Y, Zhang H, Zhao Y, Zhu B.

N Engl J Med. 2018 Oct 11;379(15):1403-1415. doi: 10.1056/NEJMoa1800474. Epub 2018 Sep 26.

8.

Enhanced Methodologies for Detecting Phenotypic Resistance in Mycobacteria.

Hammond RJH, Baron VO, Lipworth S, Gillespie SH.

Methods Mol Biol. 2018;1736:85-94. doi: 10.1007/978-1-4939-7638-6_8.

PMID:
29322461
9.

Preparing clinicians for (re-)emerging arbovirus infectious diseases in Europe.

Sigfrid L, Reusken C, Eckerle I, Nussenblatt V, Lipworth S, Messina J, Kraemer M, Ergonul O, Papa A, Koopmans M, Horby P.

Clin Microbiol Infect. 2018 Mar;24(3):229-239. doi: 10.1016/j.cmi.2017.05.029. Epub 2017 Jun 23. Review.

10.

Defining dormancy in mycobacterial disease.

Lipworth S, Hammond RJ, Baron VO, Hu Y, Coates A, Gillespie SH.

Tuberculosis (Edinb). 2016 Jul;99:131-42. doi: 10.1016/j.tube.2016.05.006. Epub 2016 May 28. Review.

PMID:
27450015
11.

Implementing systematic review techniques in chemical risk assessment: Challenges, opportunities and recommendations.

Whaley P, Halsall C, Ågerstrand M, Aiassa E, Benford D, Bilotta G, Coggon D, Collins C, Dempsey C, Duarte-Davidson R, FitzGerald R, Galay-Burgos M, Gee D, Hoffmann S, Lam J, Lasserson T, Levy L, Lipworth S, Ross SM, Martin O, Meads C, Meyer-Baron M, Miller J, Pease C, Rooney A, Sapiets A, Stewart G, Taylor D.

Environ Int. 2016 Jul-Aug;92-93:556-64. doi: 10.1016/j.envint.2015.11.002. Epub 2015 Dec 11.

12.

Phenotypic resistance in mycobacteria: is it because I am old or fat that I resist you?

Hammond RJ, Baron VO, Oravcova K, Lipworth S, Gillespie SH.

J Antimicrob Chemother. 2015 Oct;70(10):2823-7. doi: 10.1093/jac/dkv178. Epub 2015 Jul 9.

PMID:
26163401
13.

Relationships between airway hyperresponsiveness, inflammation, and calibre in asthma.

Short PM, Lipworth SI, Lipworth BJ.

Lung. 2011 Dec;189(6):493-7. doi: 10.1007/s00408-011-9328-x. Epub 2011 Oct 8.

PMID:
21984113
14.

The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.

Short PM, Williamson PA, Elder DHJ, Lipworth SIW, Schembri S, Lipworth BJ.

Chest. 2012 Jan;141(1):81-86. doi: 10.1378/chest.11-0038. Epub 2011 Jul 28.

PMID:
21799028
15.

Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.

Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ.

BMJ. 2011 May 10;342:d2549. doi: 10.1136/bmj.d2549.

Supplemental Content

Loading ...
Support Center